Company Analysis

Bausch Health Companies Inc (BHC)

NYSE: BHC · Pharmaceutical Preparations · Quebec, QC · filing with the SEC since 1996
Grade5.3
◀ Past 5.2● Present 5.9▶ Future 4.7

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

187 patents granted to the 24 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Bausch Health Companies Inc’s names, not what it holds today.

Patents granted
187
174 utility, 13 design, 1976 to Dec 31, 2025
Granted in 2025
5
Against 14 in 2024 and 14 in 2023
Applications published
292
9 of them in 2025
Names they are printed under
24
a subsidiary, a former name, its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals30
Medical technology10
Biotechnology4
Organic fine chemistry1
Computer technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name24 counted
Salix Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
63 granted
48 published
Bausch Health Ireland Limited a subsidiary
named as the applicant on its applications, in IE
0 granted
63 published
Salix Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
56 published
Bausch Health Ireland Limited a subsidiary
IE, as the owner printed on each patent
42 granted
7 published
Valeant Pharmaceuticals International, Inc. a former name
US, as the owner printed on each patent
23 granted
13 published
Santarus, Inc. a subsidiary
US, as the owner printed on each patent
7 granted
24 published
Precision Dermatology, Inc. a subsidiary
US, as the owner printed on each patent
11 granted
17 published
Solta Medical, Inc. a subsidiary
US, as the owner printed on each patent
10 granted
17 published
Orapharma, Inc. a subsidiary
US, as the owner printed on each patent
12 granted
7 published
Medicis Pharmaceutical Corporation a subsidiary
named as the applicant on its applications, in US
0 granted
14 published
Solta Medical Ireland Limited a subsidiary
IE, as the owner printed on each patent
12 granted
0 published
Valeant Pharmaceuticals International, Inc. a former name
named as the applicant on its applications, in US
0 granted
6 published
Santarus, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
5 published
Solta Medical, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
5 published
Bausch Health US, LLC a subsidiary
named as the applicant on its applications, in US
0 granted
4 published
Precision Dermatology, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
3 published
BAUSCH HEALTH US, LLC a subsidiary
US, as the owner printed on each patent
2 granted
0 published
SOLTA MEDICAL IRELAND LIMITED a subsidiary
named as the applicant on its applications, in IE
0 granted
2 published
BAUSCH HEALTH COMPANIES INC. its own name
CA, as the owner printed on each patent
1 granted
0 published
Bausch Health Americas, Inc. a subsidiary
US, as the owner printed on each patent
1 granted
0 published
Bausch Health Companies Inc. its own name
named as the applicant on its applications, in CA
0 granted
1 published
Biovail Corporation a former name
CA, as the owner printed on each patent. 1 more under the same name are not counted (printed in FR)
1 granted
0 published
Biovail Corporation International a former name
CA, as the owner printed on each patent
1 granted
0 published
HUMAX PHARMACEUTICAL S.A. a subsidiary
CO, as the owner printed on each patent
1 granted
0 published
Names not counted (24)
Bausch + Lomb Corporation
Counted on the file of Bausch & Lomb Corp, whose own name it is. 1,104 granted and 197 published under it are not counted.
Bausch + Lomb Corporation
Counted on the file of Bausch & Lomb Corp, whose own name it is. 0 granted and 80 published under it are not counted.
Synergetics, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 52 granted and 23 published under it are not counted.
Bausch + Lomb Ireland Limited
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 68 published under it are not counted.
AcuFocus, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 42 granted and 12 published under it are not counted.
Bausch + Lomb Ireland Limited
Also listed as a subsidiary by Bausch & Lomb Corp. 34 granted and 14 published under it are not counted.
Technolas Perfect Vision GmbH
Also listed as a subsidiary by Bausch & Lomb Corp. 41 granted and 4 published under it are not counted.
AcuFocus, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 35 published under it are not counted.
ELIOS Vision GmbH
Also listed as a subsidiary by Bausch & Lomb Corp. 17 granted and 16 published under it are not counted.
ELIOS Vision GmbH
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 21 published under it are not counted.
Synergetics, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 18 published under it are not counted.
Kedalion Therapeutics, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 15 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Sep 30, 202512,426,940Electrode assemblies with non-contact temperature sensing for thermal measurementsMedical technologySolta Medical Ireland Limited
Sep 16, 2025D1,093,609Tip for a medical deviceSolta Medical Ireland Limited
Sep 9, 2025D1,092,753Tip for a medical deviceSolta Medical Ireland Limited
Apr 29, 202512,285,414Methods of treating hepatic encephalopathyMedical technologySalix Pharmaceuticals, Inc.
Mar 18, 202512,251,152Ceramic applicator for transcutaneous delivery of energyMedical technologySolta Medical Ireland Limited
Dec 24, 2024D1,055,301Light therapy deviceSolta Medical Ireland Limited
Dec 3, 202412,156,688Microblade structure and method of treating tissueMedical technologySolta Medical Ireland Limited
Nov 19, 202412,146,003Ultra-pure agonists of guanylate cyclase C, method of making and using sameBiotechnologyBausch Health Ireland Limited
Nov 12, 202412,138,278Topical compositionsPharmaceuticalsBausch Health Ireland Limited
Nov 5, 202412,133,859Topical compositionsPharmaceuticalsBausch Health Ireland Limited
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 4, 20252025/0367175Solid Dispersion Forms of RifaximinPharmaceuticalsSalix Pharmaceuticals, Inc.
Nov 20, 20252025/0352569TOPICAL COMPOSITIONSPharmaceuticalsBausch Health Ireland Limited
Aug 14, 20252025/0255895TOPICAL COMPOSITIONSPharmaceuticalsBausch Health Ireland Limited
Jul 17, 20252025/0228828METHODS OF TREATING HEPATIC ENCEPHALOPATHYMedical technologySalix Pharmaceuticals, Inc.
May 29, 20252025/0171497ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAMEBiotechnologyBausch Health Ireland Limited
May 1, 20252025/0138309DEVICES FOR APPLYING ELECTROMAGNETIC ENERGY WITH PRISMATIC BEAM STEERINGMedical technologySOLTA MEDICAL IRELAND LIMITED
Mar 13, 20252025/0082616Solid Dispersion Forms of RifaximinPharmaceuticalsSalix Pharmaceuticals, Inc.
Feb 13, 20252025/0049881FORMULATIONS OF GUANYLATE CYCLSE C AGONISTS AND METHODS OF USEPharmaceuticalsBausch Health Ireland Limited
Jan 16, 20252025/0017854TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASESPharmaceuticalsBausch Health Ireland Limited
Oct 17, 20242024/0342142METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS)PharmaceuticalsSalix Pharmaceuticals, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 16 · Medical technology 3 · Biotechnology 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton BHC · research, not advice